|Stories URL||Story Heading||Home Page Paragraph||Inside Main Paragraph||Home page image||Author Name||Actions|
|kingenic-launches-qllerk-allergy-relief-in-india||Kingenic Launches Qllerk Allergy Relief in India.||Kingenic launches Qllerk-LM Allergy Relief, combination of levocetrizine dihydrochloride & montelukast tablets in India. Combination aids relief from sneezing and runny nose due to allergic skin condition and reduces airway inflammation.||
Kingenic Lifescience Pvt. Ltd. (India),is a research-led, integrated global pharmaceutical company, today announced that it has launched Qllerk-LM Allergy Relief (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film-coated tablets in Indian market, as a prescription product for the treatment of seasonal and perennial allergic rhinitis in patients above 15 years of age. Combination aids relief from sneezing and runny nose due to allergic skin condition and reduces airway inflammation.
" India is one of the key markets for us and we are consistently looking to expand our product portfolio consistently. We believe that the launch of Qllerk-LM will help enhance and expand our presence in this segment." said, Manan Kinariwala, Founder & CEO - Kingenic Lifescience Pvt. Ltd. (India)
|kingenic-introduces-qr-packaging-security||Kingenic introduces QR packaging security||Counterfeiting products cause financial losses for legitimate brands, involve social costs and losses of unpaid tax for governments. Kingenic Lifescience has implemented quick response code system on our latest packaging material to enhance traceability.||
Counterfeiting products cause financial losses for legitimate brands, involve social costs and losses of unpaid tax for governments. Kingenic Lifescience has implemented quick response code system on our latest packaging material to enhance traceability.
We have developed in-house systems to safegaurd our brands and customers. Each product & each batch will be equipped with a unique QR code which will be linked to a backlink, providing all the vital information about the product, batch & deatils. With a unique backlink for each batch within our sercured system, helps us to identify counterfeits immideatly without any effort.
With this move we at kingenic are commited to enhance the security and assure highest quality of products reach our valued consumers.
|kingenic-launches-nsaid-range||Kingenic launches NSAID range in India||Kingenic announces the Indian launch of Kinamol, it is set to enter NSAID market. NSAIDs represent a critically important class of medications, Kingenic is commited to launch several more product under this class.||
Kingenic announces the Indian launch of Kinamol, it is set to enter NSAID market. Nonsteroidal anti-inflammatory drugs (NSAIDs) represent a critically important class of medications useful in numerous musculoskeletal and inflammatory diseases, Kingenic is commited to launch several more product under this class in coming years to make a difference.
Currently Kingenic is set to launch Kinamol under 3 different combination.
Kinamol Ultra Strength
Salt Composition :
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Kinamol Ultra Strength is a combination medicine used to relieve pain and swelling in various conditions like muscle pain, joint pain and postoperative pain. Thus, it effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.
Aceclofenac (100mg) + Drotaverine (80mg)
Kinamol AD is a combination medicine used in the treatment of abdominal pain. It works effectively to reduce abdominal pain, bloating, discomfort and cramps by relaxing the muscles of the stomach and gut. It also blocks certain chemical messengers that cause pain and discomfort.
Pregabalin (75mg) + Methylcobalamin (1500mcg)
Kinamol PM is used for the treatment of neuropathic pain. It decreases the pain by modulating calcium channel activity of the nerve cells. This medicine also protects nerve fibers and heal damaged nerve cells.
"We are commited to develop and introduce new drug forms to advance the NSAID segment with easy to administer drugs in coming years and Kingenic is commited to develop nano-formulations of submicron NSAIDs featuring delivery of decreased doses without diminished efficacy." - said, Manan Kinariwala, Founder & CEO - Kingenic Lifescience Pvt. Ltd. (India)
|kingenic-enters-gastrointestinal-therapeutics-market||Kingenic enters GI therapeutics market.||We identify gastrointestinal theapeutic as an important area of treatment. With our entry into GI segment, Kingenic is commited to make maximum impact in coming years.||
Kingenic is commited to deliver advanced therapeutics covering major therapeutic areas. We identify gastrointestinal therapeutic as an important area of treatment. With our entry into GI segment, Kingenic is commited to make maximum impact in coming years.
Peptox-PD contain the active substances, pantoprazole sodium and domperidone maleate. Pantoprazole sodium is a selective proton-pump inhibitor (PPI), a medicine that reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine.
Pantoprazole sodium is used to treat adults and adolescents, 12 years of age and above, for the following:
Pantoprazole sodium is used to treat adults with stomach and duodenal ulcers.
Domperidone belongs to a group of medicines called ‘dopamine antagonists’ having anti emetic properties. It used in adults and in children to treat nausea (feeling sick) and vomiting (being sick).
Kingenic will launch full range of bio-similars in gastrointestinal therapeutic area in 2021.
|employee-induction||Making medicine accessible by expanding our reach.||By expanding our core distribution capabilities, we help healthcare professionals to serve the patients who depend on them.||
With an integrated approach from manufacturing to distribution, Kingenic expands its reach to Rajasthan, India. By expanding our core distribution capabilities, Kingenic helps healthcare professionals to serve the patients who depend on them by providing high quality pharmaceuticals & nutraceuticals.
With appointment of team of 4 scientific sales executives and 1 regional business manager in Rajasthan - India, Kingenic is expected to generate 50 positions in rural Rajasthan within one year. Kingenic affirms continuous growth in the urban region and rural coverage.
With special employee induction & scientific pharmacology training, Kingenic ensures the quality of information is passed on to healthcare professionals by our executives is up to date and scientifically strong for advanced treatment options offered by our products.